M&A / Deals Eli Lilly to Acquire Kelonia Therapeutics Big Molecule WatchOn April 20, 2026, Eli Lilly Company ( Lilly ) and Kelonia Therapeutics, Inc.Read full story pharminent May 4, 2026 (Last updated: May 4, 2026) Big Molecule Watch On April 20, 2026, Eli Lilly Company ( Lilly ) and Kelonia Therapeutics, Inc. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Gene therapy’s evidence problem–lessons from recent FDA decisionsNext: 223: An Interview With Dr. Antn Blatnik on the Molecular Mechanisms Driving Neuromuscular Disease Related Stories M&A / Deals Teva and Polpharma Biologics sign global deal for ocrelizumab biosimilar pharminent July 10, 2026 M&A / Deals GSK ends dementia alliance with Alector after setbacks pharminent July 9, 2026 M&A / Deals AstraZeneca, GSK intensify China ties with Sino Biopharm deals pharminent July 8, 2026
